ASX:RGS Regeneus (RGS) Stock Price, News & Analysis → This Apple-like Innovator is Revolutionizing Healthcare (From Wall Street Star) (Ad) Free RGS Stock Alerts Add Compare Share Share Today's Range N/A50-Day Range N/A52-Week Range N/AVolume13,076 shsAverage VolumeN/AMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get Regeneus alerts: Email Address Ad Banyan Hill PublishingThe Best AI Stock to Own in the World Today is Trading for Just $25“Titan of Tech” Bets Big on Tiny AI Company He’s made as much as 3,250,000% in just three years on companies like Facebook, Airbnb, and PayPal… But our research shows his latest investment could be his most successful venture yet.See how you can invest alongside him About Regeneus Stock (ASX:RGS)Regeneus Ltd, a clinical stage regenerative medicine company, develops cell-based therapies for the human health markets with a focus on osteoarthritis and other musculoskeletal disorders, neuropathic pain, and dermatology diseases in Australia. The company's platform technology includes Progenza, a multi-synergistic therapy, which has completed Phase I clinical trial for the treatment of osteoarthritis; and in pre-clinical stage to treat neuropathic pain. It also develops Sygenus that is in pre-clinical stage for the treatment of skin wound healing. The company was incorporated in 2007 and is headquartered in Paddington, Australia.Read More Ad Banyan Hill PublishingThe Best AI Stock to Own in the World Today is Trading for Just $25“Titan of Tech” Bets Big on Tiny AI Company He’s made as much as 3,250,000% in just three years on companies like Facebook, Airbnb, and PayPal… But our research shows his latest investment could be his most successful venture yet.See how you can invest alongside him RGS Stock News HeadlinesApril 7, 2024 | msn.comTop 10 at 10: 3D printed engines and a rejected takeover bidFebruary 26, 2024 | msn.comASX Small Caps Lunch Wrap: Markets higher yada yada… Germans legalise Pot!April 25, 2024 | Paradigm Press (Ad)Biden replacement revealed?A former CIA insider just announced a disturbing prediction… Biden will withdraw as the Democrat nominee on June 13.February 11, 2024 | finance.yahoo.comRussell 1000 RGS Retail (^R1RGSRET)February 1, 2024 | msn.comASX January winners: The best 50 stocks as ASX S&P reaches record highDecember 14, 2023 | msn.comClosing Bell: When doves fly, markets soarDecember 7, 2023 | morningstar.comRegis Corp RGSNovember 29, 2023 | msn.comCheck Up: Imugene’s oncolytic virus VAXINIA granted FDA’s Fast Track, but how effective is this novel therapy?April 25, 2024 | Paradigm Press (Ad)Biden replacement revealed?A former CIA insider just announced a disturbing prediction… Biden will withdraw as the Democrat nominee on June 13.November 25, 2023 | benzinga.comRegis Stock (NYSE:RGS) Earnings Dates and Earning CallsNovember 23, 2023 | finance.yahoo.comWe Think Shareholders Are Less Likely To Approve A Pay Rise For Regeneus Ltd's (ASX:RGS) CEO For NowNovember 20, 2023 | msn.comClosing Bell: The ASX is slightly higher, but not much cooler on MondayNovember 15, 2023 | msn.comCheck Up: Biden-Xi meeting could finally end opioids crisis in the US; and recent ASX biotech winnersOctober 10, 2023 | msn.comTop 10 at 11: Juicy berries and autonomous cop drones got the market jingling this morningSeptember 29, 2023 | msn.comASX Small Caps Lunch Wrap: Who’s marking the end of a home-delivered era today?September 26, 2023 | msn.comASX Small Caps Lunch Wrap: Which tiny town had to call the cops on the cops last week?April 27, 2023 | afr.comRegeneus LtdDecember 17, 2022 | fool.comRegis (NYSE: RGS)December 5, 2022 | seekingalpha.comOcugen: Still StrugglingSeptember 25, 2022 | finance.yahoo.comRegis Corporation (RGS)September 14, 2022 | reuters.comRGS.AX - Regeneus Ltd | Stock Price & Latest News | ReutersAugust 22, 2022 | au.finance.yahoo.comRegeneus Ltd (RGS.AX)January 17, 2022 | finance.yahoo.comWill Weakness in Regeneus Ltd's (ASX:RGS) Stock Prove Temporary Given Strong Fundamentals?See More Headlines Receive RGS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Regeneus and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeASX SectorMedical Industry Biotechnology Sub-IndustryN/A Current SymbolASX:RGS CUSIPN/A CIKN/A Webregeneus.com.au Phone61 2 9499 8010FaxN/AEmployees9,000Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-1,690,000.00 Net Margins-37.03% Pretax MarginN/A Return on Equity-355.20% Return on Assets-62.56% Debt Debt-to-Equity Ratio93.82 Current Ratio0.08 Quick Ratio0.46 Sales & Book Value Annual Sales$1.02 million Price / Sales0.00 Cash FlowN/A Price / Cash Flow21.67 Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares306,440,000Free FloatN/AMarket CapN/A OptionableNot Optionable Beta-0.24 The Next 7 Blockbuster Stocks for Growth InvestorsWondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.Get This Free Report Key ExecutivesMr. Karolis RosickasChief Executive OfficerProf. Graham Vesey Ph.D. (Age 59)Chief Scientific Officer & Executive Director Comp: $39.28kDr. Charlotte Morgan Ph.D.Head of Research & DevelopmentLing Leung HangCompany SecretaryKey Competitors180 Life SciencesNASDAQ:ATNFW3SBioOTCMKTS:TRSBF45525 (CUR.TO)TSE:CUR60 Degrees PharmaceuticalsNASDAQ:SXTPWAbcamOTCMKTS:ABCZFView All Competitors This page (ASX:RGS) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersHe Is Giving Away BitcoinCrypto Swap ProfitsBitcoin Rockets To Record High But Buy THIS InsteadParadigm Presstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyUrgent Alert: Biden's IRS Targeting Your Money – Act Fast to Protect It!American AlternativeEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest MetalsFed launches fourth dollar overhaulStansberry Research1970’s computer coder issues shocking A.I. warningTradeSmithExposed: 10 CENT Crypto to Explode April 20th?True Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Regeneus Ltd Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
